FDA Inspection 1181337 — TAIWAN BIOTECH CO., LTD.

TAIWAN BIOTECH CO., LTD. — FEI 3003598505

The FDA completed an inspection of TAIWAN BIOTECH CO., LTD. on September 20, 2022 in Taoyuan City. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
September 20, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Taoyuan City (Taiwan)